WITHDRAWN—a resource for withdrawn and discontinued drugs
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
Post-marketing drug withdrawals can be associated with various events, ranging from safety issues such as reported deaths or severe side-effects, to a multitude of non-safety problems including lack of efficacy, manufacturing, regulatory or business issues. During the last century, the majority of drugs voluntarily withdrawn from the market or prohibited by regulatory agencies was reported to be related to adverse drug reactions. Understanding the underlying mechanisms of toxicity is of utmost importance for current and future drug discovery. Here, we present WITHDRAWN, a resource for withdrawn and discontinued drugs publicly accessible at http://cheminfo.charite.de/withdrawn. Today, the database comprises 578 withdrawn or discontinued drugs, their structures, important physico-chemical properties, protein targets and relevant signaling pathways. A special focus of the database lies on the drugs withdrawn due to adverse reactions and toxic effects. For approximately one half of the drugs in the database, safety issues were identified as the main reason for withdrawal. Withdrawal reasons were extracted from the literature and manually classified into toxicity types representing adverse effects on different organs. A special feature of the database is the presence of multiple search options which will allow systematic analyses of withdrawn drugs and their mechanisms of toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The most common toxicity types associated with drug withdrawals in the United States and Europe are hepatic (21%), cardiovascular (16%), hematological (11%), neurological (9%), and carcinogenicity (8%) (Figure 2) (20).”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0720s76 · Cited by 3,705 · cited 1×
“Furthermore, the information on biological pathways and SNPs, including amino acid changes, peptide positions, MAFs, PolyPhen scores (37) and links to dbSNP, were added in the detailed record of a target.”
BackgroundData, information, knowledge and principle: back to metabolism in KEGG
Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1076 · Cited by 3,092
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
An Algorithm for Subgraph Isomorphism
Ullmann, J. R. (1976) · Journal of the ACM · doi:10.1145/321921.321925 · Cited by 2,277
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
UniProt Knowledgebase: a hub of integrated protein data
Magrane, M., & Consortium, U. (2011) · Database · doi:10.1093/database/bar009 · Cited by 1,463
Cited by
Items 101–200 of 321
Wan, H., Selvaggio, G., & Pearlstein, R. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234946 · Cited by 25
Chavan, S., Scherbak, N. N., Engwall, M., & Repsilber, D. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00459 · Cited by 24
Zhang, J. Z., Belbachir, N., Zhang, T., Liu, Y., Shrestha, R., & Wu, J. C. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.11.010 · Cited by 24
Sultan, M. A., Galil, M. S. A., Al-Qubati, M., Omar, M. M., & Barakat, A. (2020) · Applied Sciences · doi:10.3390/app10217727 · Cited by 23
Engineering Patient-on-a-Chip Models for Personalized Cancer Medicine
Caballero, D., Reis, R. L., & Kundu, S. C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36588-2_4 · Cited by 22
MicroRNA-mediated Th2 bias in methimazole-induced acute liver injury in mice
Uematsu, Y., Akai, S., Tochitani, T., Oda, S., Yamada, T., & Yokoi, T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.07.008 · Cited by 21
Peng, Y., Wu, Z., Yang, H., Cai, Y., Liu, G., Li, W., & Tang, Y. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.05.005 · Cited by 21
Exploring Low-Toxicity Chemical Space with Deep Learning for Molecular Generation
Yang, Y., Wu, Z., Yao, X., Kang, Y., Hou, T., Hsieh, C., & Liu, H. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00671 · Cited by 21
Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., KING, L. P., & McKee, M. (2019) · Health Policy · doi:10.1016/j.healthpol.2019.05.021 · Cited by 21
Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity
Tu, C., Cunningham, N. J., Zhang, M., & Wu, J. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.613837 · Cited by 21
El-Mernissi, R., Khaldan, A., Bouamrane, S., Rehman, H. M., Alaqarbeh, M., Ajana, M. A., Lakhlifi, T., & Bouachrıne, M. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2214233 · Cited by 20
Integrating Liver-Chip data into pharmaceutical decision-making processes
Levner, D., & Ewart, L. C. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2255127 · Cited by 20
Sharma, A. D., & Kaur, I. (2022) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-022-00711-5 · Cited by 20
Jain, S., Norinder, U., Escher, S. E., & Zdrazil, B. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00511 · Cited by 20
AI and the future of pharmaceutical researchPreprint
Zielinski, A. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2107.03896 · Cited by 20
Exploring Activity Profiles of PAINS and Their Structural Context in Target–Ligand Complexes
Siramshetty, V. B., Preißner, R., & Gohlke, B.-O. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00385 · Cited by 19
Self-citationZhang, H., Shen, C., Liu, R., Mao, J., Liu, C., & Mu, B. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.3975 · Cited by 19
ProfhEX: AI-based platform for small molecules liability profiling
Lunghini, F., Fava, A., Pisapia, V., Sacco, F. M., Iaconis, D., & Beccari, A. R. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00728-6 · Cited by 19
Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology
Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., KING, L. P., & McKee, M. (2019) · Health Policy · doi:10.1016/j.healthpol.2019.05.012 · Cited by 19
Pretrained transformer models for predicting the withdrawal of drugs from the market
Mazuz, E., Shtar, G., Kutsky, N., Rokach, L., & Shapira, B. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad519 · Cited by 18
FGTN: Fragment-based graph transformer network for predicting reproductive toxicity
Ren, J.-N., Chen, Q., Ye, H.-Y.-X., Cao, C., Guo, Y.-M., Yang, J., Wang, H., Khan, M. Z. I., & Chen, J. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03866-4 · Cited by 18
Onay, A., Onay, M., & Abul, O. (2017) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.02.004 · Cited by 18
Rajasingh, S., Isai, D. G., Samanta, S., Zhou, Z., Dawn, B., Kinsey, W. H., Czirók, A., & Rajasingh, J. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.183 · Cited by 18
Ivanov, D. P., Al-Rubai, A.-J. F., Grabowska, A. M., & Pratten, M. K. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.09.007 · Cited by 17
Cheng, C., Edet, U. O., Benjamin, I., Okoro, C. U., Emori, W., Mbim, E. N., Godfrey, O. C., Nwaokorie, F. O., Mbah, J. O., Ukpanukpong, R. U., et al. (2023) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2023.100994 · Cited by 17
In Silico Databases and Tools for Drug Repurposing
Serçinoğlu, O., & Özbek, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00024-9 · Cited by 16
Ciray, F., & Doğan, T. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2153830 · Cited by 15
Primum non nocere: In silico prediction of adverse drug reactions of antidepressant drugs
Güneş, S. S., Yeşil, Ç., Gürdal, E. E., Korkmaz, E. E., Yarım, M., Aydın, A., & Sipahi, H. (2021) · Computational Toxicology · doi:10.1016/j.comtox.2021.100165 · Cited by 15
Thangadurai, T. D., Manjubaashini, N., Sowndarya, A., Adaikalapandi, S., Kausalya, G., Shanmugaraju, S., Ahmad, I. B., Thomas, S., & Kalarikkal, N. (2023) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2023.128113 · Cited by 15
Onakpoya, I., Heneghan, C. J., & Aronson, J. K. (2019) · BMC Medicine · doi:10.1186/s12916-019-1294-9 · Cited by 15
Withdrawn 2.0—update on withdrawn drugs with pharmacovigilance data
Gallo, K., Goede, A., Eckert, O. A., Gohlke, B.-O., & Preißner, R. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1017 · Cited by 14
Self-citationDrugs as habitable planets in the space of dark chemical matter
Siramshetty, V. B., & Preißner, R. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.07.003 · Cited by 14
Self-citationAmano, Y., Honda, H., Sawada, R., Nukada, Y., Yamane, M., Ikeda, N., Morita, O., & Yamanishi, Y. (2020) · The Journal of Toxicological Sciences · doi:10.2131/jts.45.137 · Cited by 14
Moein, M., Heinonen, M., Mesens, N., Chamanza, R., Amuzie, C. J., Will, Y., Ceulemans, H., Kaski, S., & Herman, D. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00378 · Cited by 14
Pain-Prescription Differences - An Analysis of 500,000 Discharge Summaries
Preißner, S., Siramshetty, V. B., Dunkel, M., Steinborn, P., Luft, F. C., & Preißner, R. (2018) · Current Drug Research Reviews · doi:10.2174/1874473711666180911091846 · Cited by 14
Self-citationOnay, A., & Onay, M. (2019) · Current Computer - Aided Drug Design · doi:10.2174/1573409915666190716143601 · Cited by 14
Gao, Y., Mu, J., Liu, K., & Wang, M. (2025) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00034 · Cited by 13
Review on organ-on-chips for medicines safety assessment: A European regulatory perspective
Portela, J. M. D., Paul, P., Moriarty, O., Theunissen, P. T., Beken, S., Brendler‐Schwaab, S., de Vries, C. S., & Ponzano, S. (2025) · ALTEX · doi:10.14573/altex.2502061 · Cited by 13
Llewellyn, S. V., Kermanizadeh, A., Ude, V. C., Jacobsen, N. R., Conway, G. E., Shah, U.-K., Niemeijer, M., Moné, M. J., van de Water, B., Roy, S. K., et al. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105473 · Cited by 13
Sharma, A. D., Kaur, I., & Chauhan, A. (2023) · Phytomedicine Plus · doi:10.1016/j.phyplu.2023.100493 · Cited by 13
Füzi, B., Gurinova, J., Hermjakob, H., Ecker, G. F., & Malik‐Sheriff, R. S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.708296 · Cited by 13
Taylor, K., Ram, R., Ewart, L. C., Goldring, C. E., Russomanno, G., Aithal, G. P., Kostrzewski, T. M., Bauch, C., Wilkinson, J. M., Modi, S., et al. (2025) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2025.1536756 · Cited by 12
Engineering Cardiovascular Tissue Chips for Disease Modeling and Drug Screening Applications
Chan, A., & Huang, N. F. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.673212 · Cited by 12
Insilico toxicity prediction by using ProTox-II computational tools
Kumar, S. D., Rajasekaran, A., & Kumar, K. S. (2024) · Asia-Pacific Journal of Pharmacotherapy & Toxicology · doi:10.32948/ajpt.2024.07.22 · Cited by 12
Sharma, A. D., & Kaur, I. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2022.03.011 · Cited by 12
A proof-of-concept study poised to remodel the drug development process
Nahle, Z. A. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.1053588 · Cited by 12
Chenchula, S., Kumar, S., & Varthya, S. B. (2019) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2019.11242 · Cited by 12
Show drugs work before selling them
Sipp, D., McCabe, C. J., & Rasko, J. E. J. (2017) · Nature · doi:10.1038/543174a · Cited by 11
Current use of animal models of disease for nonclinical safety testing
Blanset, D. L., Hutt, J. A., & Morgan, S. J. (2020) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2020.02.005 · Cited by 11
Impacts of diphenylamine NSAID halogenation on bioactivation risks
Schleiff, M. A., Payakachat, S., Schleiff, B. M., Swamidass, S. J., Boysen, G., & Miller, G. P. (2021) · Toxicology · doi:10.1016/j.tox.2021.152832 · Cited by 11
Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers
Bahlol, M., Bushell, M., Khojah, H. M. J., & Dewey, R. S. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.04.006 · Cited by 11
Abady, M. M., Jeong, J., Kwon, H., Assiri, A. M., Cho, J., & Saadeldin, I. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1412188 · Cited by 11
From Human Pluripotent Stem Cells to 3D Cardiac Microtissues: Progress, Applications and Challenges
Branco, M. A., Cabral, J. M. S., & Diogo, M. M. (2020) · Bioengineering · doi:10.3390/bioengineering7030092 · Cited by 11
Park, Y.-G., Park, N. K., Lee, Y., Pramudito, M. A., Son, Y., Park, H., Qauli, A. I., Choi, S. W., Ban, K., Choi, J., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.030 · Cited by 10
Effects of major analgesics on male fertility: A systematic literature review
Capelo, M. F., Monteiro, P. B., & Anastácio, B. M. (2024) · JBRA · doi:10.5935/1518-0557.20240020 · Cited by 10
Pantoja, L. V. P. D. S., Trindade, S. S. A., Carneiro, A. D. S., Silva, J. P. B., da Paixão, T. P., Romeiro, C. F. R., de Moraes, C. S. P., Pinto, A. C. G., Raposo, N. R. B., & de Andrade, M. A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i6.28542 · Cited by 10
Béquignon, O. J. M., Pawar, G. V., van de Water, B., Cronin, M., & van Westen, G. J. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11535-1 · Cited by 10
Okai, Y., Matsune, K., Yamanaka, K., Matsui, T., Pfeiffer, E. R., Harada, K., Kohara, H., Miyawaki, A., Ozaki, H., Wagoner, M. P., et al. (2020) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2020.106893 · Cited by 10
Cardiovascular Drugs: an Insight of In Silico Drug Design Tools
Sarma, H., Upadhyaya, M., Gogoi, B., Phukan, M., Kashyap, P., Das, B., Devi, R., & Sharma, H. K. (2021) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-021-09587-w · Cited by 10
Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies
Hagan, J. B., Ender, E., Divekar, R. D., Pongdee, T., & Rank, M. A. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.11.009 · Cited by 10
Computer-aided technologies in drug discovery and toxicity prediction
Pawar, B., Behera, S. K., Tekade, M., Al‐Shar’i, N. A., & Tekade, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15840-7.00004-x · Cited by 9
A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents
Žusinaite, E., Ianevski, A., Niukkanen, D., Poranen, M. M., Bjørås, M., Afset, J. E., Tenson, T., Velagapudi, V., Merits, A., & Kainov, D. E. (2018) · Viruses · doi:10.3390/v10080423 · Cited by 9
Production of Highly Uniform Midbrain Organoids from Human Pluripotent Stem Cells
Yao, X., Kang, J. H., Kim, K.-P., Shin, H., Jin, Z., Guo, H., Xu, Y., Li, Y., Hali, S., Kwon, J., et al. (2023) · Stem Cells International · doi:10.1155/2023/3320211 · Cited by 9
Prospect of reprogramming replication licensing for cancer drug development
Kyei-Barffour, I., & Acheampong, D. O. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111190 · Cited by 9
Satsuka, A., Hayashi, S., Yanagida, S., Ono, A., & Kanda, Y. (2022) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2022.107227 · Cited by 9
Rosell-Hidalgo, A., Bruhn, C., Shardlow, E., Barton, R. W., Ryder, S., Samatov, T. R., Hackmann, A., Aquino, G. R., dos Reis, M. F., Galatenko, V., et al. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2273378 · Cited by 8
Strategies for Redesigning Withdrawn Drugs to Enhance Therapeutic Efficacy and Safety: A Review
Patel, C., Shakeel, A., Mall, R., Alawi, K. M., Ozerov, I. V., Zhavoronkov, A. A., & Castiglione, F. (2025) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.70004 · Cited by 8
Post-Marketing Drug Withdrawals: A Review
Rao, N., & Powar, R. (2023) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-023-02994-y · Cited by 8
Comprehensive Network Map of ADME‐Tox Databases
Canault, B., Bourg, S., Vayer, P., & Bonnet, P. (2017) · Molecular Informatics · doi:10.1002/minf.201700029 · Cited by 8
Sharma, A. D., & Kaur, I. (2022) · Chemistry Africa · doi:10.1007/s42250-021-00302-3 · Cited by 8
Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?
Lane, J. D., & Tinker, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00890 · Cited by 8
Computational Approaches for Predicting hERG Activity
Alves, V. M., Braga, R. C., & Andrade, C. H. (2018) · Wiley eBooks · doi:10.1002/9781119282594.ch3 · Cited by 8
A Machine Learning Approach Predicts Tissue-Specific Drug Adverse EventsPreprint
Madhukar, N. S., Gayvert, K. M., Gilvary, C. M., & Elemento, O. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/288332 · Cited by 8
Yu, X., Chen, Y., Chen, L., Li, W., Wang, Y., Tang, Y., & Liu, G. (2024) · Molecular Informatics · doi:10.1002/minf.202400169 · Cited by 7
Burgers, E. J., Sharma, R. P., Eugenio, C. J., Heldring, M. M., Wijaya, L. S., van de Water, B., & Beltman, J. B. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012844 · Cited by 8
Amrita, C., Sharma, A. D., Kaur, I., Sarkar, A., & Panja, A. S. (2025) · Chemical Papers · doi:10.1007/s11696-025-04011-w · Cited by 7
Rebollo-Ramirez, S., Krokowski, S., Lobato‐Márquez, D., Thomson, M., Pennisi, I., Mostowy, S., & Larrouy-Maumus, G. J. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00038 · Cited by 7
Assessing consistency across functional screening datasets in cancer cells
Cai, L., Liu, H., Minna, J. D., DeBerardinis, R. J., Xiao, G., & Xie, Y. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab423 · Cited by 7
Lubamba, B., Jensen, T. C., & McClelland, R. (2022) · Applied Sciences · doi:10.3390/app12062786 · Cited by 7
Sharma, A. D., Kaur, I., & Chauhan, A. (2023) · Phytomedicine Plus · doi:10.1016/j.phyplu.2023.100440 · Cited by 7
Bitam, S., Hamadache, M., & Hanini, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2217926 · Cited by 7
Sharma, A. D., Kaur, I., & Chauhan, A. (2023) · Chemistry Africa · doi:10.1007/s42250-023-00717-0 · Cited by 7
Al‐Odat, O. S., Nelson, E., Budak-Alpdoǧan, T., Jonnalagadda, S. C., Desai, D. H., & Pandey, M. K. (2024) · Cancers · doi:10.3390/cancers16132381 · Cited by 6
Li, X., Chen, L., Yu, H., Xiong, L., Song, W., Li, X., Liu, G., Li, W., & Tang, Y. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01618 · Cited by 6
Sharma, A. D., Kaur, I., & Chauhan, A. (2023) · Russian Agricultural Sciences · doi:10.3103/s106836742302012x · Cited by 6
Naga, D., Dimitrakopoulou, S., Roberts, S., Husar, E., Mohr, S., Booler, H. S., & Musvasva, E. (2023) · Scientific Reports · doi:10.1038/s41598-023-41899-4 · Cited by 7
Jaiswal, S. V., Agarwal, N., & Gupta, M. (2021) · Results in Chemistry · doi:10.1016/j.rechem.2021.100186 · Cited by 6
Karadkhelkar, N. M., Gupta, P., Barasa, L., Chilamakuri, R., Hlordzi, C. K., Acharekar, N., Agarwal, S., Chen, Z., & Yoganathan, S. (2024) · ChemMedChem · doi:10.1002/cmdc.202300715 · Cited by 5
Kciuk, M., Machura, G., Mujwar, S., Marciniak, B., Koszelska, K., Smarzewska, S., Mojzych, M., & Kontek, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-02835-w · Cited by 5
Berg, J., Heinze, J., Niemeyer, D., Hellgren, J., Jaiswal, H., Löwa, A., Hocke, A. C., Namro, I., Drosten, C., Kurreck, J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125543 · Cited by 5
Open-Access Activity Prediction Tools for Natural Products. Case Study: hERG Blockers
Mayr, F., Vieider, C., Temml, V., Stuppner, H., & Schuster, D. (2019) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-030-14632-0_6 · Cited by 5
Gu, Y., Wang, Y., Wu, Z., Li, W., Liu, G., & Tang, Y. (2023) · Molecular Informatics · doi:10.1002/minf.202200284 · Cited by 5
Kim, M. W., Lee, S.-G., Kim, J., Jeong, K. S., Lee, Y. H., Lee, S., Park, J. H., Jeong, Y., Lee, M., Kim, Y., et al. (2024) · Molecular & Cellular Toxicology · doi:10.1007/s13273-024-00485-z · Cited by 5
Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.
Crittenden, D., Gallagher, R., del Bosch, F. M., Fox, D. M., & Kleiman, L. B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1419772 · Cited by 5
Huang, T., Lin, K., Machado‐Vieira, R., Soares, J. C., Jiang, X., & Kim, Y. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03971-1 · Cited by 5
Analysis of time-course drug response in rat cardiomyocytes cultured on a pattern of islands
Okumura, S., Hirano, Y., Maki, Y., & Komatsu, Y. (2018) · The Analyst · doi:10.1039/c8an01033a · Cited by 5
Pharmacoepidemiology and pharmacovigilance
Delcher, C., Moga, D. C., Li, Y., Muñoz, M. A., Sohn, M., & Bae, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820007-0.00051-9 · Cited by 5
TractaViewer: a genome-wide tool for preliminary assessment of therapeutic target druggability
Pearson, N., Malki, K., Evans, D. A. P., Vidler, L. R., Ruble, C., Scherschel, J., Eastwood, B. J., & Collier, D. A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz270 · Cited by 5
Mathpal, S., Priyamvada, P., Ashok, G., Joshi, T., Saha, D., Mukherjee, A., Roy, B., Ramaiah, S., & Anbarasu, A. (2025) · Results in Chemistry · doi:10.1016/j.rechem.2025.102506 · Cited by 4
Evangelista, D., Nelson, E. R., Tehan, B., Bagnolini, G., Roberti, M., & Bottegoni, G. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02888 · Cited by 4
Metadata
- Authors
- Siramshetty, V. B., Nickel, J., Omieczynski, C., Gohlke, B.-O., Drwal, M. N., & Preissner, R.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- German Cancer Research Center (DE)
- Corresponding author
- Drwal, Malgorzata N.
- Preissner, Robert
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-08
- Volume
- 44
- Issue
- D1
- Pages
- D1080-D1086
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702851
- OpenAlex
- W2147670638
- Cited by
- 286
- References
- 45
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 35 · 2023: 36 · 2022: 27 · 2021: 28 · 2020: 37 · 2019: 24 · 2018: 30 · 2017: 12 · 2016: 12 · 2015: 1
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by-nc)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- drug withdrawal, adverse drug reactions, drug toxicity, toxicity mechanisms, drug safety, drug discovery, chemical databases, protein targets, signaling pathways, physicochemical properties
- MeSH terms
- Pharmaceutical Preparations, Humans, Proteins, Signal Transduction, Internet, Polymorphism, Single Nucleotide, Drug Recalls, Safety-Based Drug Withdrawals, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.